Managing Type 2 Diabetes: The Impact of Secure Patient-Provider Messaging
Secure messaging presents an opportunity for patients and healthcare providers to collaborate on self-management issues like glycemic control, diet, and exercise.
Type 2 Diabetes
TYPE 2 DIABETES
-
-
In-Hospital Tramadol Use Increases Hypoglycemia Risk in T1D, T2D
Results indicate that blood glucose monitoring should be conducted in hospitalized patients with diabetes. -
Type 2 Diabetes and Antidepressant Drug Use: Is There a Causal Link?
Updated meta-analysis confirms the association between antidepressant drug (AD) use and incident diabetes. Future studies should be aimed at evaluating the effect of single AD on the risk of developing T2D. -
Addressing Psychological Insulin Resistance in Patients With Diabetes
Learn about strategies to reduce a patient’s reluctance to initiate insulin therapy, a phenomenon called psychological insulin resistance.
Video
Latest News
SGLT2 Inhibitor Reduces BP Without Changing Sodium Excretion
Researchers studied the effect of dapagliflozin on cumulative sodium excretion in patients with type 2 diabetes and preserved kidney function while sodium intake was being strictly controlled.
Fish Intake, PUFA Levels May Mitigate GAD65 Antibody Diabetes Risk
Does eating fish, particularly fatty fish, reduce the risk of adult-onset diabetes for those who are susceptible?
Albuminuria Down in Adults With Newly Diagnosed T2DM
From 1988 to 2018, there were reductions seen in the prevalence of albuminuria and improvements in glycemic, blood pressure, and lipid control among adults with newly diagnosed T2D.
Women With Lifelong Irregular or Long Menstrual Cycles at Higher Risk for T2D
Is the regularity of a woman’s menstrual cycles during her reproductive life a significant and independent predictor for T2D risk?
Type 1 Diabetes Glycemic Control Improved During Pandemic Lockdown
On average, glycemic control improved during lockdown among people living with type 1 diabetes.
Dapagliflozin Under Review for Chronic Kidney Disease
The FDA has granted Priority Review to dapagliflozin (Farxiga) for the treatment of new or worsening CKD.
Euglycemic DKA Identified in Patients With COVID-19, Diabetes
In a case report recently published, five cases of euDKA are described in patients with T2DM using SGLT2i who developed SARS-CoV-2 infection.
FDA Approves First Generic Version of Glucagon Emergency Kit
The FDA has approved the first generic equivalent of Glucagon Emergency Kit (Lilly), according to Amphastar Pharmaceuticals.
Weekly Icodec Therapy and Glargine Similarly Lower Blood Glucose Levels in T2D
Investigators compared glucose-lowering efficacy and safety profile of once-weekly treatment with insulin icodec and once-daily insulin glargine U100 in patients with type 2 diabetes.
Age at T2DM Diagnosis Inversely Linked to Risk for Adverse Outcomes
Younger age at diagnosis of T2D is associated with an increased risk for mortality and vascular disease.
-
Loading...
-
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Type 2 Diabetes
